Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Effectiveness of bevacizumab added to standard chemotherapy in metastatic colorectal cancer: final results for first-line treatment from the ITACa randomized clinical trialPassardi, A. ; Nanni, O. ; Tassinari, D. ; Turci, D. ; Cavanna, L. ; Fontana, A. ; Ruscelli, S. ; Mucciarini, C. ; Lorusso, V. ; Ragazzini, A. ; Frassineti, G.L. ; Amadori, D.Annals of oncology, 2015-06, Vol.26 (6), p.1201-1207 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Adjuvant T-DM1 versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer: subgroup analyses from KATHERINEMamounas, E.P. ; Untch, M. ; Mano, M.S. ; Huang, C.-S. ; Geyer Jr, C.E. ; von Minckwitz, G. ; Wolmark, N. ; Pivot, X. ; Kuemmel, S. ; DiGiovanna, M.P. ; Kaufman, B. ; Kunz, G. ; Conlin, A.K. ; Alcedo, J.C. ; Kuehn, T. ; Wapnir, I. ; Fontana, A. ; Hackmann, J. ; Polikoff, J. ; Saghatchian, M. ; Brufsky, A. ; Yang, Y. ; Zimovjanova, M. ; Boulet, T. ; Liu, H. ; Tesarowski, D. ; Lam, L.H. ; Song, C. ; Smitt, M. ; Loibl, S.Annals of oncology, 2021-08, Vol.32 (8), p.1005-1014 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Final results of the TANIA randomised phase III trial of bevacizumab after progression on first-line bevacizumab therapy for HER2-negative locally recurrent/metastatic breast cancerVrdoljak, E. ; Marschner, N. ; Zielinski, C. ; Gligorov, J. ; Cortes, J. ; Puglisi, F. ; Aapro, M. ; Fallowfield, L. ; Fontana, A. ; Inbar, M. ; Kahan, Z. ; Welt, A. ; Lévy, C. ; Brain, E. ; Pivot, X. ; Putzu, C. ; González Martín, A. ; de Ducla, S. ; Easton, V. ; von Minckwitz, G.Annals of oncology, 2016-11, Vol.27 (11), p.2046-2052 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Alcohol consumption and risk of Hodgkin's lymphoma and multiple myeloma: a multicentre case–control studyGorini, G. ; Stagnaro, E. ; Fontana, V. ; Miligi, L. ; Ramazzotti, V. ; Amadori, D. ; Rodella, S. ; Tumino, R. ; Crosignani, P. ; Vindigni, C. ; Fontana, A. ; Vineis, P. ; Seniori Costantini, A.Annals of oncology, 2007-01, Vol.18 (1), p.143-148 [Periódico revisado por pares]Oxford: Elsevier LtdTexto completo disponível |